These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 21239736)

  • 21. [Effects of a JAK inhibitor, AG490, on proliferation and survivin expression of breast cancer cell line MDA-MB-231].
    Yu C; Deng HY
    Ai Zheng; 2006 Oct; 25(10):1227-31. PubMed ID: 17059765
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential roles for the coactivators CBP and p300 on TCF/beta-catenin-mediated survivin gene expression.
    Ma H; Nguyen C; Lee KS; Kahn M
    Oncogene; 2005 May; 24(22):3619-31. PubMed ID: 15782138
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lack of cross-desensitization between leptin and prolactin signaling pathways despite the induction of suppressor of cytokine signaling 3 and PTP-1B.
    Roy AF; Benomar Y; Bailleux V; Vacher CM; Aubourg A; Gertler A; Djiane J; Taouis M
    J Endocrinol; 2007 Nov; 195(2):341-50. PubMed ID: 17951545
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The antiproliferative effects of pterostilbene on breast cancer in vitro are via inhibition of constitutive and leptin-induced Janus kinase/signal transducer and activator of transcription activation.
    McCormack D; Schneider J; McDonald D; McFadden D
    Am J Surg; 2011 Nov; 202(5):541-4. PubMed ID: 21944294
    [TBL] [Abstract][Full Text] [Related]  

  • 25. leptin-induced growth stimulation of breast cancer cells involves recruitment of histone acetyltransferases and mediator complex to CYCLIN D1 promoter via activation of Stat3.
    Saxena NK; Vertino PM; Anania FA; Sharma D
    J Biol Chem; 2007 May; 282(18):13316-25. PubMed ID: 17344214
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Leptin receptor expression and cell signaling in breast cancer.
    Frankenberry KA; Skinner H; Somasundar P; McFadden DW; Vona-Davis LC
    Int J Oncol; 2006 Apr; 28(4):985-93. PubMed ID: 16525650
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estrogen receptor alpha inhibits p53-mediated transcriptional repression: implications for the regulation of apoptosis.
    Sayeed A; Konduri SD; Liu W; Bansal S; Li F; Das GM
    Cancer Res; 2007 Aug; 67(16):7746-55. PubMed ID: 17699779
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel leptin antagonist peptide inhibits breast cancer growth in vitro and in vivo.
    Catalano S; Leggio A; Barone I; De Marco R; Gelsomino L; Campana A; Malivindi R; Panza S; Giordano C; Liguori A; Bonofiglio D; Liguori A; Andò S
    J Cell Mol Med; 2015 May; 19(5):1122-32. PubMed ID: 25721149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prostate cancer cell proliferation is influenced by leptin.
    Somasundar P; Frankenberry KA; Skinner H; Vedula G; McFadden DW; Riggs D; Jackson B; Vangilder R; Hileman SM; Vona-Davis LC
    J Surg Res; 2004 May; 118(1):71-82. PubMed ID: 15093720
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of subcutaneous leptin injections on hypothalamic gene profiles in lean and ob/ob mice.
    Duan J; Choi YH; Hartzell D; Della-Fera MA; Hamrick M; Baile CA
    Obesity (Silver Spring); 2007 Nov; 15(11):2624-33. PubMed ID: 18070753
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distinct activities of suppressor of cytokine signaling (SOCS) proteins and involvement of the SOCS box in controlling G-CSF signaling.
    van de Geijn GJ; Gits J; Touw IP
    J Leukoc Biol; 2004 Jul; 76(1):237-44. PubMed ID: 15107455
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of JAK2/STAT3 signaling by osteopontin promotes tumor growth in human breast cancer cells.
    Behera R; Kumar V; Lohite K; Karnik S; Kundu GC
    Carcinogenesis; 2010 Feb; 31(2):192-200. PubMed ID: 19926637
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protective effect of resveratrol on obesity-related osteoarthritis via alleviating JAK2/STAT3 signaling pathway is independent of SOCS3.
    Jiang M; He J; Gu H; Yang Y; Huang Y; Xu X; Liu L
    Toxicol Appl Pharmacol; 2020 Feb; 388():114871. PubMed ID: 31881177
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Leptin signaling targets the thyrotropin-releasing hormone gene promoter in vivo.
    Guo F; Bakal K; Minokoshi Y; Hollenberg AN
    Endocrinology; 2004 May; 145(5):2221-7. PubMed ID: 14764630
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Leptin upregulates telomerase activity and transcription of human telomerase reverse transcriptase in MCF-7 breast cancer cells.
    Ren H; Zhao T; Wang X; Gao C; Wang J; Yu M; Hao J
    Biochem Biophys Res Commun; 2010 Mar; 394(1):59-63. PubMed ID: 20171193
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytokine-inducible SH2-containing protein suppresses PRL signaling by binding the PRL receptor.
    Dif F; Saunier E; Demeneix B; Kelly PA; Edery M
    Endocrinology; 2001 Dec; 142(12):5286-93. PubMed ID: 11713228
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of age on leptin induced skeletal muscle signalling.
    Guadalupe-Grau A; Larsen S; Guerra B; Calbet JA; Dela F; Helge JW
    Acta Physiol (Oxf); 2014 May; 211(1):214-28. PubMed ID: 24605926
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adiponectin inhibits leptin signalling via multiple mechanisms to exert protective effects against hepatic fibrosis.
    Handy JA; Fu PP; Kumar P; Mells JE; Sharma S; Saxena NK; Anania FA
    Biochem J; 2011 Dec; 440(3):385-95. PubMed ID: 21846328
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cucurbitacin IIa: a novel class of anti-cancer drug inducing non-reversible actin aggregation and inhibiting survivin independent of JAK2/STAT3 phosphorylation.
    Boykin C; Zhang G; Chen YH; Zhang RW; Fan XE; Yang WM; Lu Q
    Br J Cancer; 2011 Mar; 104(5):781-9. PubMed ID: 21304528
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acrp30 inhibits leptin-induced metastasis by downregulating the JAK/STAT3 pathway via AMPK activation in aggressive SPEC-2 endometrial cancer cells.
    Wu X; Yan Q; Zhang Z; Du G; Wan X
    Oncol Rep; 2012 May; 27(5):1488-96. PubMed ID: 22327423
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.